期刊文献+

胸腔灌注洛铂与顺铂治疗肺癌性胸腔积液的疗效和护理 被引量:13

Effect and nursing care of lobaplatin and cisplatin in the treatment of pleural perfusion in patients with lung cancer
暂未订购
导出
摘要 目的观察胸腔灌注洛铂(LBP)与顺铂(DDP)治疗肺癌性胸腔积液的疗效、毒副反应及护理。方法 60例确诊为肺癌性胸腔积液的患者,经胸腔置管引流术排尽积液后,随机分为LBP组和DDP组,每组30例。胸腔内灌注治疗,比较各组的疗效、患者的生活质量和毒副反应。结果 LBP组有效率为86.7%,DDP组有效率为63.3%(P<0.05)。LBP组消化道不良反应发生率为20.0%,DDP组消化道不良反应发生率为46.7%(P<0.05)。LBP组的Kamofsky评分较DDP组有显著提高(P<0.05)。结论 LBP胸腔灌注治疗肺癌性胸腔积液疗效肯定,良好的护理是治疗成功的关键。 Objective To observe the effect and adverse reactions and nursing care of lobaplatin (LBP) and cisplatin (DDP) in the treatment of pleural perfusion in patients with lung cancer. Methods 60 lung cancer patients with pleural effusion after chest drainage were randomly divided into two groups according pathological types: 30 cases in the LBP group (Group A) and 30 cases in the DDP group (Group B). The therapeutic effect, 1ife quality and toxic side effects were evaluated. Results The response rate was 86.7% and 63.3% respectively in the group A and B (P〈0.05). The rate of gastrointestinal side effect was 20.0% and 46.7% respectively in the group A and B (P〈0.05). The Karnofsky scores of the group A were higher than that in the group B (P〈0.05). Conclusion The intracavity injection of LBP is more effective in the treatment of malignant pleural effusion. The better nursing care is the key factor for successful treatment.
作者 盛志红
机构地区 南京市胸科医院
出处 《临床肺科杂志》 2014年第4期715-717,共3页 Journal of Clinical Pulmonary Medicine
关键词 肺癌 胸腔积液 恶性 洛铂 顺铂 护理 lung cancer pleural effusion malignant lobaplatin cisplatin nursing care
  • 相关文献

参考文献5

二级参考文献18

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2张频,冯奉仪,吴令英,胡毅,刘基崴,高亚杰,关晓倩,南克俊,索爱莉,王秀问,张茂宏,张文东,李朝午,张阳,赵金波.奈达铂治疗恶性肿瘤的临床研究[J].中华肿瘤杂志,2006,28(3):230-234. 被引量:62
  • 3陈丽昆,徐光川,管忠震,梁颖,杨群英.奈达铂或顺铂联合紫杉醇治疗晚期非小细胞肺癌的随机对照研究[J].中华肿瘤杂志,2007,29(6):437-440. 被引量:36
  • 4孙燕.临床肿瘤内科手册.4版.北京:人民卫生出版社,2003.571.
  • 5Ostrowski MJ.An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin.Cancer,1986,5:721-727.
  • 6Postmus PE,Brambilla E,Chansky K,el al.The IASLC lung cancer staging project:proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.J Thorac Oncol,2007,2:686-693.
  • 7张仲苗,戴海斌,周权.铜绿假单胞菌注射液对K562细胞株处理后淋巴细胞凋亡及免疫功能的影响[J].中国药学杂志,2007,42(16):1224-1227. 被引量:8
  • 8Barnes PJ. Chronic obstructive pulmonary disease[J].New England Journal of Medicine,2000,(04):269-280.
  • 9Liu ZB,Hou YF,Dong M. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of capases in the human breast cancer cell lines[J].Journal of Cellular Biochemistry,2009,(01):195-206.
  • 10Millar JW,Hunter AM,Horne NW,et al.Intrapleral immunotherepy with CP in recurrent malignant pleural effusions[].Thorax.1980

共引文献102

同被引文献136

引证文献13

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部